Life sciences business OptiBiotix Health plc (LON:OPTI) told shareholders it is now able to make dividend payments in future, should it want to.
The cancellation of its share premium account has been ratified, creating reserves that are available for distribution to shareholders.
"I am pleased to report that both shareholders and the courts have confirmed the capital reduction. This allows OptiBiotix to make future dividend or 'dividend in specie' distributions to the company's shareholders should it be appropriate to do so. This is part of OptiBiotix's strategy of building value across its divisions and where possible releasing value back to shareholders," said Stephen O'Hara, the chief executive officer of OptiBiotix.